CN116115722A - Traditional Chinese medicine composition eye ointment for preventing and treating hyperopia of children and teenagers and preparation method thereof - Google Patents
Traditional Chinese medicine composition eye ointment for preventing and treating hyperopia of children and teenagers and preparation method thereof Download PDFInfo
- Publication number
- CN116115722A CN116115722A CN202310226025.2A CN202310226025A CN116115722A CN 116115722 A CN116115722 A CN 116115722A CN 202310226025 A CN202310226025 A CN 202310226025A CN 116115722 A CN116115722 A CN 116115722A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- traditional chinese
- children
- eye ointment
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 55
- 239000000203 mixture Substances 0.000 title claims abstract description 50
- 239000003885 eye ointment Substances 0.000 title claims abstract description 30
- 201000006318 hyperopia Diseases 0.000 title claims abstract description 27
- 230000004305 hyperopia Effects 0.000 title claims abstract description 27
- 206010020675 Hypermetropia Diseases 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title abstract description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 30
- 201000010041 presbyopia Diseases 0.000 claims abstract description 29
- 239000000843 powder Substances 0.000 claims abstract description 28
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims abstract description 20
- 238000000034 method Methods 0.000 claims abstract description 17
- 239000000463 material Substances 0.000 claims abstract description 14
- 210000000582 semen Anatomy 0.000 claims abstract description 13
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims abstract description 10
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229940075507 glyceryl monostearate Drugs 0.000 claims abstract description 10
- 229940057995 liquid paraffin Drugs 0.000 claims abstract description 10
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 claims abstract description 10
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229920000136 polysorbate Polymers 0.000 claims abstract description 10
- 239000004302 potassium sorbate Substances 0.000 claims abstract description 10
- 235000010241 potassium sorbate Nutrition 0.000 claims abstract description 10
- 229940069338 potassium sorbate Drugs 0.000 claims abstract description 10
- 239000003871 white petrolatum Substances 0.000 claims abstract description 10
- 235000021355 Stearic acid Nutrition 0.000 claims abstract description 9
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000008117 stearic acid Substances 0.000 claims abstract description 9
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 claims abstract description 6
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 4
- 244000293323 Cosmos caudatus Species 0.000 claims abstract description 3
- 235000005956 Cosmos caudatus Nutrition 0.000 claims abstract description 3
- 235000014375 Curcuma Nutrition 0.000 claims abstract description 3
- 241000628997 Flos Species 0.000 claims abstract description 3
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims abstract description 3
- 229940095102 methyl benzoate Drugs 0.000 claims abstract description 3
- 229960004274 stearic acid Drugs 0.000 claims abstract description 3
- 244000164480 Curcuma aromatica Species 0.000 claims abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 41
- 239000000706 filtrate Substances 0.000 claims description 23
- 238000003756 stirring Methods 0.000 claims description 18
- 239000002674 ointment Substances 0.000 claims description 17
- 238000001816 cooling Methods 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 9
- 239000006071 cream Substances 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 2
- 230000007812 deficiency Effects 0.000 abstract description 11
- 210000004185 liver Anatomy 0.000 abstract description 11
- 210000003734 kidney Anatomy 0.000 abstract description 8
- 210000004369 blood Anatomy 0.000 abstract description 7
- 239000008280 blood Substances 0.000 abstract description 7
- 230000004438 eyesight Effects 0.000 abstract description 6
- 206010010356 Congenital anomaly Diseases 0.000 abstract description 5
- 230000008506 pathogenesis Effects 0.000 abstract description 4
- 230000001939 inductive effect Effects 0.000 abstract description 2
- -1 liquid paraffin Substances 0.000 abstract 1
- 210000001508 eye Anatomy 0.000 description 30
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 14
- 230000001954 sterilising effect Effects 0.000 description 14
- 238000004659 sterilization and disinfection Methods 0.000 description 14
- 230000000694 effects Effects 0.000 description 12
- 238000012360 testing method Methods 0.000 description 10
- 229940079593 drug Drugs 0.000 description 9
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 8
- 235000003097 Artemisia absinthium Nutrition 0.000 description 8
- 240000001851 Artemisia dracunculus Species 0.000 description 8
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 8
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 8
- 244000035851 Chrysanthemum leucanthemum Species 0.000 description 8
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 8
- 244000163122 Curcuma domestica Species 0.000 description 8
- 241000405414 Rehmannia Species 0.000 description 8
- 239000001138 artemisia absinthium Substances 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 8
- 235000003392 Curcuma domestica Nutrition 0.000 description 7
- 235000017784 Mespilus germanica Nutrition 0.000 description 7
- 244000182216 Mimusops elengi Species 0.000 description 7
- 235000000560 Mimusops elengi Nutrition 0.000 description 7
- 235000007837 Vangueria infausta Nutrition 0.000 description 7
- 235000003373 curcuma longa Nutrition 0.000 description 7
- 238000000227 grinding Methods 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 7
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 7
- 229960002216 methylparaben Drugs 0.000 description 7
- 235000013976 turmeric Nutrition 0.000 description 7
- 241000675108 Citrus tangerina Species 0.000 description 6
- 244000236658 Paeonia lactiflora Species 0.000 description 6
- 235000008598 Paeonia lactiflora Nutrition 0.000 description 6
- 208000001491 myopia Diseases 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 241000700199 Cavia porcellus Species 0.000 description 4
- 241000112528 Ligusticum striatum Species 0.000 description 4
- 240000003705 Senecio vulgaris Species 0.000 description 4
- 241000700198 Cavia Species 0.000 description 3
- 241001146210 Senecio scandens Species 0.000 description 3
- 230000005856 abnormality Effects 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 230000004379 myopia Effects 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 2
- 206010015958 Eye pain Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 241000212322 Levisticum officinale Species 0.000 description 2
- 206010052143 Ocular discomfort Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 210000005252 bulbus oculi Anatomy 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 210000004709 eyebrow Anatomy 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 238000002430 laser surgery Methods 0.000 description 2
- 239000001645 levisticum officinale Substances 0.000 description 2
- 208000014733 refractive error Diseases 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- 201000009487 Amblyopia Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 208000027205 Congenital disease Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010725 Conjunctival irritation Diseases 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 241001106477 Paeoniaceae Species 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 208000029091 Refraction disease Diseases 0.000 description 1
- 241000780602 Senecio Species 0.000 description 1
- 208000004350 Strabismus Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000004430 ametropia Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- 229940107666 astragalus root Drugs 0.000 description 1
- 230000004323 axial length Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 238000007427 paired t-test Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 238000010181 skin prick test Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/241—Lead; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/43—Cuscutaceae (Dodder family), e.g. Cuscuta epithymum or greater dodder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Marine Sciences & Fisheries (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition eye ointment for preventing and treating hyperopia of children and teenagers and a preparation method thereof, and belongs to the technical field of traditional Chinese medicine preparation. The traditional Chinese medicine composition eye ointment for preventing and treating the hyperopia of the children and the teenagers comprises the following components in parts by weight: traditional Chinese medicine mixture: 47-79 parts of auxiliary materials: 421-579 parts; the traditional Chinese medicine mixture comprises the following components: radix rehmanniae Preparata, semen Cuscutae, radix Paeoniae alba, fructus Lycii, rhizoma Ligustici Chuanxiong, curcuma rhizome, folium Artemisiae Argyi, flos Chrysanthemi Indici, herba Senecionis Scandentis, pericarpium Citri Reticulatae viride, rhizoma Acori Graminei, and Margarita powder; the auxiliary materials comprise the following components: stearic acid, glyceryl monostearate, liquid paraffin, white vaseline, triethanolamine, glycerol, tween, methyl benzoate, potassium sorbate and Lithargyrum powder. Aiming at the pathogenesis of presbyopia caused by congenital deficiency of children and teenagers, the invention provides the traditional Chinese medicine formula paste for tonifying liver and kidney, tonifying qi and blood, dredging meridian passage and inducing resuscitation and improving eyesight, which is matched with a special use method, is self-taken by children, and is safe and effective.
Description
Technical Field
The invention belongs to the technical field of traditional Chinese medicine preparation, and in particular relates to traditional Chinese medicine composition eye ointment for preventing and treating hyperopia of children and teenagers and a preparation method thereof.
Background
Unlike myopia, the cause of childhood presbyopia is not overuse of the eye, but a congenital condition that begins at the fetal stage. Children with hyperopia develop slowly, have difficulty in looking far and near, and have greater daily eye pressure. In addition, the social information network is rapidly developed, the short-distance ocular tension is larger and larger in life, study and work of people, the school of children and teenagers is heavy, the ocular time and intensity are greatly increased before, so that serious ocular fatigue, eyeball pain, dizziness, nausea and other discomfort can be easily caused for children and teenagers with hyperopia, and serious hyperopia is often accompanied with amblyopia and strabismus. The children's life, study and growth are greatly influenced.
Currently, methods for preventing and treating presbyopia include wearing glasses, laser surgery, and the like. Besides the defect of treating the symptoms without treating the root causes, the laser surgery has potential side effects on eyes. The method for preventing and treating presbyopia by traditional Chinese medicine comprises acupuncture points, eye plaster, massage, etc. The traditional Chinese medicine of the eye ointment is insufficient in compatibility of medicines and is not specific, and the prescription is general and is used for all patients with ametropia including presbyopia. In fact, the causes of childhood presbyopia and myopia are fundamentally different. Myopia is caused by overuse of the eyes, while hyperopia is congenital disease, liver and kidney deficiency, deficiency of qi and blood, and inability to see eyes. Presbyopia has its own specific pathogenesis, and should be treated by syndrome differentiation alone and the prescription should be dispatched alone.
At present, no traditional Chinese medicine formula eye cream specially aiming at independent dialectical treatment of congenital presbyopia of children and teenagers exists, and the invention can fill the gap. The eye ointment has unique formula, is safe and convenient to use, can effectively promote the rehabilitation of presbyopia of children and teenagers, and can help the eyesight health of children.
Disclosure of Invention
Aiming at the pathogenesis of presbyopia caused by congenital deficiency of children and teenagers, the invention provides the traditional Chinese medicine formula paste for tonifying liver and kidney, tonifying qi and blood, dredging meridian passage and inducing resuscitation and improving eyesight, which is matched with a special use method, is self-taken by children, and is safe and effective.
In order to achieve the technical purpose, the invention adopts the following technical scheme.
A traditional Chinese medicine composition eye ointment for preventing and treating children and teenagers from hyperopia is prepared from a traditional Chinese medicine composition and auxiliary materials in parts by weight:
47-79 parts of a traditional Chinese medicine mixture,
421-579 parts of auxiliary materials.
A traditional Chinese medicine composition eye ointment for preventing and treating children and teenagers from hyperopia is prepared from a traditional Chinese medicine mixture and auxiliary materials in parts by weight:
63 parts of a Chinese medicinal mixture,
500 parts of auxiliary materials.
The traditional Chinese medicine mixture comprises the following components in parts by weight:
the traditional Chinese medicine mixture comprises the following components in parts by weight:
the traditional Chinese medicine mixture comprises the following components in parts by weight:
wherein, the auxiliary materials comprise the following components in parts by weight:
wherein, the auxiliary materials comprise the following components in parts by weight:
a preparation method of a traditional Chinese medicine composition eye ointment for preventing and treating hyperopia of children and teenagers comprises the following steps:
(1) The Chinese medicinal composition is prepared by decocting the filtrate: mixing radix rehmanniae Preparata, semen Cuscutae, radix Paeoniae alba, fructus Lycii, rhizoma Ligustici Chuanxiong, curcuma rhizome, folium Artemisiae Argyi, flos Chrysanthemi Indici, herba Senecionis Scandentis, pericarpium Citri Reticulatae viride and rhizoma Acori Graminei, decocting in water for 2 times (1 hr each time), mixing decoctions, and filtering with 400 mesh sieve to obtain Chinese medicinal decoction;
(2) Preparing presbyopia ointment: mixing stearic acid, glyceryl monostearate, liquid paraffin and white vaseline to obtain an oil phase, mixing the Chinese medicinal decoction, triethanolamine, glycerol, tween, methyl benzoate and potassium sorbate to obtain water phase, respectively heating the oil phase and water phase to 85deg.C in water, slowly pouring the oil phase into the water phase, stirring to obtain cream with milky yellow and semisolid, cooling the cream to 55deg.C, adding Margarita powder and Lithargyrum powder, and stirring for 2 hr until the cream is condensed.
Compared with the prior art, the invention has the beneficial effects that:
aiming at the specific pathogenesis of presbyopia of children and teenagers, the invention has the advantages of full and specific syndrome differentiation, low price of traditional Chinese medicine prescription, convenient use, safety and effectiveness.
The principal drugs in the invention are prepared rehmannia root and semen cuscutae, which are good drugs for tonifying deficiency, and have definite effect and mild effect. The children and teenagers hyperopia are congenital deficiency, liver and kidney deficiency, prepared rehmannia root, semen cuscutae liver and kidney deficiency and eye fluid, liquid, qi and blood deficiency, and the two components are monarch drugs, and the dosage is the largest. Far and near objects are unclear, so that the far and near objects are more prone to eyestrain than a near eye, qi, blood and body fluid are more prone to deficiency, channels and collaterals around eyes are blocked, and eyes cannot be seen. In the formula, white peony root, medlar supplements qi and blood, nourishes liver and kidney, szechuan lovage rhizome, turmeric and wormwood activate blood and remove stasis, warm meridians and dredge collaterals, and the medicines are ministerial medicines, and the dosage is slightly inferior to that of monarch medicines. Overuse of the eyes causes qi stagnation and fluid consumption in the eyes, deficiency of liver and kidney, and hyperactivity of fire due to yin deficiency. In the formula, the wild chrysanthemum flower, the groundsel herb, the heat and the toxin are cleared, the fire is discharged, the liver is calmed and the eyesight is improved; pearl powder for suppressing hyperactive liver, subsiding yang, nourishing liver yin, and improving eyesight. Qing Pi, with the actions of activating qi and resolving stagnation, is good at Shu Ganyu. The four are adjuvant drugs with small dosage. The grassleaf sweelflag rhizome has the advantages of pungent and fragrant smell, bitter and dry taste, warmth and general, and mild action, is suitable for children and teenagers to refresh and restore consciousness, and is the drug with the minimum dosage.
The presbyopia ointment of the invention is used in the following way, 3 times a day for 5 minutes each time. The eye ointment is applied on the periphery of the eye, and the index finger starts from the Ming acupoint of the eye of the eyebrow and goes from the upper orbit to the Tongziliao acupoint of the eyebrow, then goes to the temple, goes to the lower orbital margin, goes to the four-white acupoint, and finally goes to the inner canthus of the inner side of the nose, and then the index finger presses, is retracted and stays at the acupoint, and self feels soreness and distending pain.
Detailed Description
The invention is further described below in connection with specific embodiments.
Example 1
(one), articles preparation
1 stage of electronic balance;
1 stove;
1 pan;
2 beakers;
1 stage of stirrer;
2 thermometer at 100deg.C.
Secondly, preparing a Chinese medicinal composition water decoction filtrate
9 g of prepared rehmannia root, 9 g of semen cuscutae, 6 g of white paeony root, 6 g of medlar, 6 g of szechuan lovage rhizome, 6 g of turmeric, 6 g of wormwood, 3 g of wild chrysanthemum flower, 3 g of groundsel, 3 g of green tangerine peel and 3 g of grassleaf sweelflag rhizome;
the above components are placed in 10 times of water and decocted for 2 times, each time for 1 hour, the decocted liquid is combined and filtered by a 400-mesh sieve, and 1000 milliliters of Chinese medicinal composition water decocted filtrate is obtained.
(III) preparing presbyopia ointment
1. Stearic acid 100 g
2. Glyceryl monostearate 50 g
3. Liquid paraffin 50 g
4. White vaseline 100 g
5. 1000 ml of Chinese medicine decoction filtrate
6. Triethanolamine 50 g
7. Glycerol 100 g
8. Tween 10 g
9. Methyl paraben 5 g
10. Potassium sorbate 5 g
11. Pearl powder 3 g
12. Lithargyrum powder 30 g
Placing the components 1, 2, 3 and 4 in a beaker to form an oil phase; the components 5, 6, 7, 8, 9, 10 were placed in another beaker to be aqueous. And heating the two beakers to 85 ℃ in a water-proof manner at the same time, slowly pouring the oil phase into the water phase, and continuously stirring until the paste is milky yellow in the process, wherein the semisolid is the emulsified paste. Cooling the paste to 55deg.C, grinding the components 11 and 12 into powder, adding, and stirring for 2 hr until the paste is condensed.
And (3) notes:
1. ultraviolet lamp sterilization is needed for 2 hours in the manufacturing environment;
2. the container is manufactured by high-pressure sterilization;
3. the paste is stirred in the same direction so as to avoid whipping.
Example 2
(one), articles preparation
1 stage of electronic balance;
1 stove;
1 pan;
2 beakers;
1 stage of stirrer;
2 thermometer at 100deg.C.
Secondly, preparing a Chinese medicinal composition water decoction filtrate
6 g of prepared rehmannia root, 12 g of semen cuscutae, 5 g of white peony root, 7 g of medlar, 5 g of ligusticum wallichii, 7 g of turmeric, 5 g of wormwood, 2 g of wild chrysanthemum flower, 4 g of senecio scandens, 2 g of green tangerine peel and 4 g of grassleaf sweelflag rhizome;
the above components are placed in 10 times of water and decocted for 2 times, each time for 1 hour, the decocted liquid is combined and filtered by a 400-mesh sieve, and 1000 milliliters of Chinese medicinal composition water decocted filtrate is obtained.
(III) preparing presbyopia ointment
1. Stearic acid 90 g
2. Glyceryl monostearate 40 g
3. 40 g of liquid paraffin
4. White vaseline 90 g
5. 1000 ml of Chinese medicine decoction filtrate
6. Triethanolamine 40 g
7. Glycerol 90 g
8. Tween 8 g
9. Methyl paraben 3 g
10. Potassium sorbate 2 g
11. Pearl powder 2 g
12. Lithargyrum powder 15 g
Placing the components 1, 2, 3 and 4 in a beaker to form an oil phase; the components 5, 6, 7, 8, 9, 10 were placed in another beaker to be aqueous. And heating the two beakers to 85 ℃ in a water-proof manner at the same time, slowly pouring the oil phase into the water phase, and continuously stirring until the paste is milky yellow in the process, wherein the semisolid is the emulsified paste. Cooling the paste to 55deg.C, grinding the components 11 and 12 into powder, adding, and stirring for 2 hr until the paste is condensed.
And (3) notes:
1. ultraviolet lamp sterilization is needed for 2 hours in the manufacturing environment;
2. the container is manufactured by high-pressure sterilization;
3. the paste is stirred in the same direction so as to avoid whipping.
Example 3
(one), articles preparation
1 stage of electronic balance;
1 stove;
1 pan;
2 beakers;
1 stage of stirrer;
2 thermometer at 100deg.C.
Secondly, preparing a Chinese medicinal composition water decoction filtrate
12 g of prepared rehmannia root, 6 g of semen cuscutae, 7 g of white peony root, 5 g of medlar, 7 g of ligusticum wallichii, 5 g of turmeric, 7 g of wormwood, 4 g of wild chrysanthemum flower, 2 g of groundsel, 4 g of green tangerine peel and 2 g of grassleaf sweelflag rhizome;
the above components are placed in 10 times of water and decocted for 2 times, each time for 1 hour, the decocted liquid is combined and filtered by a 400-mesh sieve, and 1000 milliliters of Chinese medicinal composition water decocted filtrate is obtained.
(III) preparing presbyopia ointment
1. Stearic acid 110 g
2. Glyceryl monostearate 60 g
3. Liquid paraffin 60 g
4. White vaseline 110 g
5. 1000 ml of Chinese medicine decoction filtrate
6. Triethanolamine 60 g
7. Glycerol 110 g
8. Tween 12 g
9. Methyl paraben 7 g
10. Potassium sorbate 7 g
11. Pearl powder 4 g
12. Lithargyrum powder 40 g
Placing the components 1, 2, 3 and 4 in a beaker to form an oil phase; the components 5, 6, 7, 8, 9, 10 were placed in another beaker to be aqueous. And heating the two beakers to 85 ℃ in a water-proof manner at the same time, slowly pouring the oil phase into the water phase, and continuously stirring until the paste is milky yellow in the process, wherein the semisolid is the emulsified paste. Cooling the paste to 55deg.C, grinding the components 11 and 12 into powder, adding, and stirring for 2 hr until the paste is condensed.
And (3) notes:
1. ultraviolet lamp sterilization is needed for 2 hours in the manufacturing environment;
2. the container is manufactured by high-pressure sterilization;
3. the paste is stirred in the same direction so as to avoid whipping.
Example 4
(one), articles preparation
1 stage of electronic balance;
1 stove;
1 pan;
2 beakers;
1 stage of stirrer;
2 thermometer at 100deg.C.
Secondly, preparing a Chinese medicinal composition water decoction filtrate
8 g of prepared rehmannia root, 10 g of semen cuscutae, 5 g of white peony root, 7 g of medlar, 5 g of ligusticum wallichii, 7 g of turmeric, 5 g of wormwood, 2 g of wild chrysanthemum flower, 4 g of senecio scandens, 2 g of green tangerine peel and 4 g of grassleaf sweelflag rhizome;
the above components are placed in 10 times of water and decocted for 2 times, each time for 1 hour, the decocted liquid is combined and filtered by a 400-mesh sieve, and 1000 milliliters of Chinese medicinal composition water decocted filtrate is obtained.
(III) preparing presbyopia ointment
1. Stearic acid 100 g
2. Glyceryl monostearate 50 g
3. Liquid paraffin 50 g
4. White vaseline 100 g
5. 1000 ml of Chinese medicine decoction filtrate
6. Triethanolamine 50 g
7. Glycerol 100 g
8. Tween 10 g
9. Methyl paraben 5 g
10. Potassium sorbate 5 g
11. Pearl powder 3 g
12. Lithargyrum powder 30 g
Placing the components 1, 2, 3 and 4 in a beaker to form an oil phase; the components 5, 6, 7, 8, 9, 10 were placed in another beaker to be aqueous. And heating the two beakers to 85 ℃ in a water-proof manner at the same time, slowly pouring the oil phase into the water phase, and continuously stirring until the paste is milky yellow in the process, wherein the semisolid is the emulsified paste. Cooling the paste to 55deg.C, grinding the components 11 and 12 into powder, adding, and stirring for 2 hr until the paste is condensed.
And (3) notes:
1. ultraviolet lamp sterilization is needed for 2 hours in the manufacturing environment;
2. the container is manufactured by high-pressure sterilization;
3. the paste is stirred in the same direction so as to avoid whipping.
Example 5
(one), articles preparation
1 stage of electronic balance;
1 stove;
1 pan;
2 beakers;
1 stage of stirrer;
2 thermometer at 100deg.C.
Secondly, preparing a Chinese medicinal composition water decoction filtrate
10 g of prepared rehmannia root, 8 g of semen cuscutae, 5 g of white peony root, 7 g of medlar, 5 g of ligusticum wallichii, 7 g of turmeric, 5 g of wormwood, 2 g of wild chrysanthemum flower, 4 g of senecio scandens, 2 g of green tangerine peel and 4 g of grassleaf sweelflag rhizome;
the above components are placed in 10 times of water and decocted for 2 times, each time for 1 hour, the decocted liquid is combined and filtered by a 400-mesh sieve, and 1000 milliliters of Chinese medicinal composition water decocted filtrate is obtained.
(III) preparing presbyopia ointment
1. Stearic acid 100 g
2. Glyceryl monostearate 50 g
3. Liquid paraffin 50 g
4. White vaseline 100 g
5. 1000 ml of Chinese medicine decoction filtrate
6. Triethanolamine 50 g
7. Glycerol 100 g
8. Tween 10 g
9. Methyl paraben 5 g
10. Potassium sorbate 5 g
11. Pearl powder 3 g
12. Lithargyrum powder 30 g
Placing the components 1, 2, 3 and 4 in a beaker to form an oil phase; the components 5, 6, 7, 8, 9, 10 were placed in another beaker to be aqueous. And heating the two beakers to 85 ℃ in a water-proof manner at the same time, slowly pouring the oil phase into the water phase, and continuously stirring until the paste is milky yellow in the process, wherein the semisolid is the emulsified paste. Cooling the paste to 55deg.C, grinding the components 11 and 12 into powder, adding, and stirring for 2 hr until the paste is condensed.
And (3) notes:
1. ultraviolet lamp sterilization is needed for 2 hours in the manufacturing environment;
2. the container is manufactured by high-pressure sterilization;
3. the paste is stirred in the same direction so as to avoid whipping.
Comparative example 1
(one), articles preparation
1 stage of electronic balance;
1 stove;
1 pan;
2 beakers;
1 stage of stirrer;
2 thermometer at 100deg.C.
Secondly, preparing a Chinese medicinal composition water decoction filtrate
Semen astragali complanati 9 g, semen cuscutae 9 g, radix paeoniae alba 6 g, fructus lycii 6 g, rhizoma ligustici wallichii 6 g, rhizoma curcumae longae 6 g, wormwood 6 g, green tangerine orange peel 3 g and rhizoma acori graminei 3 g;
the above components are placed in 10 times of water and decocted for 2 times, each time for 1 hour, the decocted liquid is combined and filtered by a 400-mesh sieve, and 1000 milliliters of Chinese medicinal composition water decocted filtrate is obtained.
(III) preparing presbyopia ointment
1. Stearic acid 100 g
2. Glyceryl monostearate 50 g
3. Liquid paraffin 50 g
4. White vaseline 100 g
5. 1000 ml of Chinese medicine decoction filtrate
6. Triethanolamine 50 g
7. Glycerol 100 g
8. Tween 10 g
9. Methyl paraben 5 g
10. Potassium sorbate 5 g
11. Pearl powder 3 g
12. Lithargyrum powder 30 g
Placing the components 1, 2, 3 and 4 in a beaker to form an oil phase; the components 5, 6, 7, 8, 9, 10 were placed in another beaker to be aqueous. And heating the two beakers to 85 ℃ in a water-proof manner at the same time, slowly pouring the oil phase into the water phase, and continuously stirring until the paste is milky yellow in the process, wherein the semisolid is the emulsified paste. Cooling the paste to 55deg.C, grinding the components 11 and 12 into powder, adding, and stirring for 2 hr until the paste is condensed.
And (3) notes:
1. ultraviolet lamp sterilization is needed for 2 hours in the manufacturing environment;
2. the container is manufactured by high-pressure sterilization;
3. the paste is stirred in the same direction so as to avoid whipping.
Description: comparative example 1 the same as in example 1 was repeated except that the prepared rehmannia root was replaced with semen astragali Complanati and the wild chrysanthemum flower and senecio in the prescription were deleted.
Comparative example 2
(one), articles preparation
1 stage of electronic balance;
1 stove;
1 pan;
2 beakers;
1 stage of stirrer;
2 thermometer at 100deg.C.
Secondly, preparing a Chinese medicinal composition water decoction filtrate
9 g of astragalus root, 9 g of ginseng, 6 g of angelica, 6 g of white peony root, 6 g of medlar, 6 g of turmeric, 6 g of wormwood, 3 g of wild chrysanthemum flower, 3 g of groundsel and 3 g of borneol. The above components are placed in 10 times of water and decocted for 2 times, each time for 1 hour, the decocted liquid is combined and filtered by a 400-mesh sieve, and 1000 milliliters of Chinese medicinal composition water decocted filtrate is obtained.
(III) preparing presbyopia ointment
1. Stearic acid 100 g
2. Glyceryl monostearate 50 g
3. Liquid paraffin 50 g
4. White vaseline 100 g
5. 1000 ml of Chinese medicine decoction filtrate
6. Triethanolamine 50 g
7. Glycerol 100 g
8. Tween 10 g
9. Methyl paraben 5 g
10. Potassium sorbate 5 g
11. Pearl powder 3 g
12. Lithargyrum powder 30 g
Placing the components 1, 2, 3 and 4 in a beaker to form an oil phase; the components 5, 6, 7, 8, 9, 10 were placed in another beaker to be aqueous. And heating the two beakers to 85 ℃ in a water-proof manner at the same time, slowly pouring the oil phase into the water phase, and continuously stirring until the paste is milky yellow in the process, wherein the semisolid is the emulsified paste. Cooling the paste to 55deg.C, grinding the components 11 and 12 into powder, adding, and stirring for 2 hr until the paste is condensed.
And (3) notes:
1. ultraviolet lamp sterilization is needed for 2 hours in the manufacturing environment;
2. the container is manufactured by high-pressure sterilization;
3. the paste is stirred in the same direction so as to avoid whipping.
Animal toxicity test
1. Acute periocular skin allergy test:
10 healthy guinea pigs with the age of 3 months are selected, the weight is 450-700g, and the male and female are half. The upper part of the guinea pig in the eyes was dehaired at about 1cm by 1cm in area 24 hours before administration. The presbyopia ointment of example 1 was uniformly smeared on the dehairing zone, the ointment and the eye ointment were removed after the fixation and closure with a medical non-irritating adhesive tape for 24 hours and 24 hours, the skin and systemic toxicant signs of the animals were observed for 7 days, and the animals were sacrificed by the neck pulling method after the test was completed to conduct general pathological observation.
Test results: the test animals did not die during the test period, the activities were fed normally, and no abnormalities were seen in the whole body skin. Cadavers were generally necropsied, and no obvious abnormalities were seen in heart, liver, spleen, lung, kidney.
Conclusion: guinea pig has no acute skin anaphylaxis to tested eye ointment
2. Acute conjunctival irritation test
6 healthy guinea pigs with the age of 3 months are selected, the weight is 450-700g, and the male and female are half. In the test, the water decoction of the traditional Chinese medicine composition obtained in the embodiment 1 of the application is placed to normal temperature, and is sucked by a sterile dropper, then 1 drop of the water decoction is dripped into the left eye of each guinea pig, and the right eye is used for comparison observation. 30min,1h,24h,48h,72h after dripping the test substance, and observing the conjunctival congestion of the eyes of the guinea pigs.
Test results: no ocular abnormalities were observed at each time point after instillation of the test article, and during the observation period, animals were fed normally with activity and no death.
Conclusion: the Chinese medicinal composition water decoction used in the application has no obvious irritation to guinea pig conjunctiva
Clinical data and preferences for presbyopia cream
1. Case sources
Collecting 160 hyperopic teenager patients from a certain ophthalmic hospital in Zhengzhou city from 11 months 2021 to 4 months 2022.
2. Diagnostic criteria and classification
Diagnostic criteria are formulated with reference to diagnosis and classification criteria for hyperopia in Chinese ophthalmology. The diagnosis criterion for hyperopia is a refractive error in which the eye, in a state of accommodation relaxation, after parallel rays pass through the refractive system of the eye, a focal point is formed behind the retina, and the axial length of the eyeball is smaller than the refractive power thereof.
Classification of hyperopia degree:
1) Mild presbyopia: farsightedness < +3.0D
2) Moderate presbyopia: hyperopia of +3.0D to +6.0D
3) High presbyopia: distance vision of > +6.0D
3. Exclusion criteria
1) Is not in compliance with the above diagnostic and inclusion criteria
2) Patients with other eye diseases and have influence on curative effect determination
3) Patients with other systemic diseases and mental diseases
4) Those undergoing other treatment methods
4. Grouping and treatment method
160 patients which are taken into observation are randomly divided into four groups according to the order of clinic visits, and all cases are completed in the whole process without falling cases. Before treatment, the comparison between the two groups of examination results has no statistical difference, and the data has comparability. Wherein, treatment of 1 group of 40 cases was given the presbyopia ointment treatment described in example 1, and applied 3 times daily over the observation period; treatment of group 2, 40 cases, with presbyopia ointment as described in comparative example 1, applied 3 times daily over the observation period; treatment of 3 groups of 40 cases, treatment with presbyopia ointment as described in comparative example 2 was given, and applied 3 times daily over the observation period; treatment of 4 groups of 40 cases, administration of cool compress gel with bosom and eye moistening effects, and application of cool compress gel with eye moistening effect was performed 3 times daily during observation period. After 2 months, the two groups of cases are subjected to index detection, and the curative effect is observed.
5. Effect determination
The use effect is divided into effective and ineffective.
The method is effective: the original subjective visual discomfort, such as blurred vision, eye soreness, eye distension, eye pain, headache and the like, disappears; or the wearing mirror power is reduced by more than 50 degrees; or the naked eyes are far away, and the near vision is improved by more than 0.1 compared with the prior art. Any one of the above steps is effective.
Invalidation: subjective visual discomfort such as blurred vision, eye soreness, eye distension, eye pain, headache, etc. still exists; or the lens wearing degree is unchanged; or the wearing power is deepened more forward; or the naked eyes are far away, and the near vision is not improved; or the naked eyes are far away, and the near vision is reduced by more than 0.1 compared with the front.
6. Statistical method
SPSS17.0 software was used for data processing. The pre-and post-treatment metering data of each group adopts paired t test, the comparison among groups adopts variance analysis, the test level a=0.05, and the difference is statistically significant when p is less than 0.05.
7. Observation result
Group of | Eye ointment name | Case (personal) | Effective and effective | Invalidation of | Effective rate of |
Treatment group 1 | EXAMPLE 1 eye ointment | 40 | 37 | 3 | 92.5% |
Treatment group 2 | Comparative example 1 eye ointment | 40 | 32 | 8 | 80.0% |
Treatment 3 groups | Comparative example 2 eye ointment | 40 | 31 | 9 | 77.5% |
Treatment 4 groups | Eye-moistening cold compress gel | 40 | 28 | 12 | 70.0% |
8. Conclusion(s)
The observation results show that the treatment of the treatment group 1 and the treatment group 2 can improve the clinical symptoms of teenager hyperopia patients, and compared with the eye-moistening cold compress gel, the treatment effect of the hyperopic ointment is more obvious. Also, the efficacy of comparative examples 1 and 2 was significantly lower than the ointment of example 1.
The foregoing is a further elaboration of the present invention in connection with the detailed description, and it is not intended that the invention be limited to the specific embodiments shown, but rather that a number of simple deductions or substitutions be made by one of ordinary skill in the art without departing from the spirit of the invention, should be considered as falling within the scope of the invention as defined in the appended claims.
Claims (8)
1. A traditional Chinese medicine composition eye ointment for preventing and treating children and teenagers from hyperopia is characterized by being prepared from a traditional Chinese medicine composition and auxiliary materials in parts by weight:
47-79 parts of a traditional Chinese medicine mixture,
421-579 parts of auxiliary materials.
2. The traditional Chinese medicine composition eye ointment for preventing and treating children and teenagers from hyperopia according to claim 2, which is characterized by being prepared from a traditional Chinese medicine mixture and auxiliary materials in parts by weight:
63 parts of a Chinese medicinal mixture,
500 parts of auxiliary materials.
8. a method for preparing the traditional Chinese medicine composition eye ointment for preventing and treating hyperopia of children and teenagers according to any one of claims 1-7, which is characterized by comprising the following steps:
(1) The Chinese medicinal composition is prepared by decocting the filtrate: mixing radix rehmanniae Preparata, semen Cuscutae, radix Paeoniae alba, fructus Lycii, rhizoma Ligustici Chuanxiong, curcuma rhizome, folium Artemisiae Argyi, flos Chrysanthemi Indici, herba Senecionis Scandentis, pericarpium Citri Reticulatae viride and rhizoma Acori Graminei, decocting in water for 2 times (1 hr each time), mixing decoctions, and filtering with 400 mesh sieve to obtain Chinese medicinal decoction;
(2) Preparing presbyopia ointment: mixing stearic acid, glyceryl monostearate, liquid paraffin and white vaseline to obtain an oil phase, mixing the Chinese medicinal decoction, triethanolamine, glycerol, tween, methyl benzoate and potassium sorbate to obtain water phase, respectively heating the oil phase and water phase to 85deg.C in water, slowly pouring the oil phase into the water phase, stirring to obtain cream with milky yellow and semisolid, cooling the cream to 55deg.C, adding Margarita powder and Lithargyrum powder, and stirring for 2 hr until the cream is condensed.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310226025.2A CN116115722B (en) | 2023-03-09 | 2023-03-09 | A Chinese medicinal eye ointment for preventing and treating hyperopia of children and teenagers, and its preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310226025.2A CN116115722B (en) | 2023-03-09 | 2023-03-09 | A Chinese medicinal eye ointment for preventing and treating hyperopia of children and teenagers, and its preparation method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116115722A true CN116115722A (en) | 2023-05-16 |
CN116115722B CN116115722B (en) | 2023-07-25 |
Family
ID=86297557
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310226025.2A Active CN116115722B (en) | 2023-03-09 | 2023-03-09 | A Chinese medicinal eye ointment for preventing and treating hyperopia of children and teenagers, and its preparation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116115722B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109620909A (en) * | 2018-10-08 | 2019-04-16 | 车丽萍 | Chinese medicine composition, Chinese medicine eye mask and its preparation and application |
CN111450170A (en) * | 2019-01-18 | 2020-07-28 | 任玉娟 | Eyesight-improving and eye-protecting composition for children and application and preparation method thereof |
-
2023
- 2023-03-09 CN CN202310226025.2A patent/CN116115722B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109620909A (en) * | 2018-10-08 | 2019-04-16 | 车丽萍 | Chinese medicine composition, Chinese medicine eye mask and its preparation and application |
CN111450170A (en) * | 2019-01-18 | 2020-07-28 | 任玉娟 | Eyesight-improving and eye-protecting composition for children and application and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN116115722B (en) | 2023-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101732506B (en) | External oculentum for treating amblyopia, astigmatism, strabismus, myopia and visual fatigue of teenagers | |
CN102698079B (en) | Medicine composition for treating xerophthalmia and preparation method and application thereof | |
CN103083609B (en) | Traditional Chinese medicine for treating cervical spondylosis, lumbar intervertebral disc herniation and ankylosing spondylitis | |
CN100459958C (en) | Chinese medicine heat therapy eyeshade and its medicine | |
CN104069364A (en) | Traditional Chinese medicine for treating optic atrophy | |
CN111035748A (en) | Traditional Chinese medicine composition for improving myopia, external application preparation for improving myopia and eye patch for improving myopia | |
CN112826900B (en) | Traditional Chinese medicine composition for treating seborrheic alopecia and pharmaceutical preparation thereof | |
CN107260808A (en) | A kind of liniment for alleviating visual fatigue and its production and use | |
CN105708936A (en) | Traditional Chinese medicinal composition for treating myopia, amblyopia and asthenopia | |
CN112138046A (en) | Medicine composition for treating xerophthalmia and asthenopia and preparation method and application thereof | |
CN116115722B (en) | A Chinese medicinal eye ointment for preventing and treating hyperopia of children and teenagers, and its preparation method | |
CN112121104B (en) | Traditional Chinese medicine composition for relieving asthenopia and preventing and treating myopia | |
CN116211984B (en) | A Chinese medicinal composition eye ointment for preventing and treating myopia of children and teenagers, and its preparation method | |
CN114010591A (en) | Externally-applied traditional Chinese medicine gel paste for treating asthenopia and preparation method thereof | |
CN112618660A (en) | Traditional Chinese medicine pearl eye ointment for nourishing blood and improving eyesight and preparation method thereof | |
CN102210841A (en) | Chinese medicinal preparation for treating central serous retinopathy | |
CN112336838A (en) | Traditional Chinese medicine formula eye drop for treating xerophthalmia and preparation method thereof | |
CN110522815A (en) | A kind of Chinese medicine composition and preparation method thereof for treating disease of eye | |
CN104606367A (en) | Traditional Chinese medicine eye drop for treating liver and kidney insufficiency myopia, and preparation method thereof | |
CN108498615A (en) | A kind of Chinese herb medicine eye health-care patch and preparation method thereof improving eyes based on nitric oxide principle | |
CN115429869B (en) | Traditional Chinese medicine composition for treating cold-dampness obstruction type lumbago and preparation method thereof | |
CN102836316A (en) | Chinese medicine preparation for treating amblyopia | |
CN1073600A (en) | The preparation method of the Chinese medicine preparation of treatment pseudomyopia | |
CN117599149A (en) | A Chinese medicinal composition for improving eyesight, and its preparation method | |
SR | Efficacy of Sida cordifolia Linn. decoction as vehicle of drug (anupanam) in the management of joint disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |